Will New Covid Treatments Be as Elusive for Poor Countries ...
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain […]
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain […]
“It causes huge distress to tell a family, ‘We can’t serve you,’” said one state hospice organization director. […]
But many panel members said J. & J. recipients might also benefit from the option of a Pfizer-BioNTech […]
Published: October 14, 2021 at 05:57PM from NYT Health https://ift.tt/3BHYNnR
Rising immunity and modest changes in behavior may explain why cases are declining, but much remains unknown, scientists […]
The trend confirmed warnings that the coronavirus pandemic would undermine progress against other infectious diseases around the world. […]
People who have received the company’s one-shot vaccine may benefit from a booster with another brand. F.D.A. advisers […]
A U.S. panel is proposing a shift away from the use of low-dose aspirin in many people at […]
The agency said also said that it didn’t have enough time to independently review much of the raw […]
The new recommendations are aimed at food manufacturers and restaurants. Some experts say they don’t go far enough. […]
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)